Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuru Hashiramoto

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Endocrine Journal|August 30, 2005
A nonsense mutation in the Arg345 of the insulin receptor gene in a Japanese type A insulin-resistant patientMitsuru Hashiramoto, Haruhiko Osawa, Mitsuhiro Ando, et al.
The Journal of Nutritional Biochemistry|December 10, 2014
Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic miceYukiko Kanda, Mitsuru Hashiramoto, Masashi Shimoda, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonistYukiko Kanda, Masashi Shimoda, Sumiko Hamamoto, et al.
Endocrine Journal|August 27, 2009
Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygoteYukiko Kanda, Masashi Shimoda, Kazuhito Tawaramoto, et al.
Diabetology & Metabolic Syndrome|September 22, 2015
Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)Kazuhito Tawaramoto, Hideaki Kaneto, Mitsuru Hashiramoto, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetesTomohiko Kimura, Hideaki Kaneto, Masashi Shimoda, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2009
Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergyFumiko Kawasaki, Shinji Kamei, Fuminori Tatsumi, et al.
Journal of Diabetes Investigation|May 14, 2015
Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infectionShinji Kamei, Hideaki Kaneto, Mitsuru Hashiramoto, et al.
Molecular and Cellular Endocrinology|June 28, 2015
Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expressionHidenori Hirukawa, Hideaki Kaneto, Masashi Shimoda, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2016
Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 DiabetesTomohiko Kimura, Hideaki Kaneto, Yukiko Kanda-Kimura, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Endocrine Journal|August 30, 2005
A nonsense mutation in the Arg345 of the insulin receptor gene in a Japanese type A insulin-resistant patientMitsuru Hashiramoto, Haruhiko Osawa, Mitsuhiro Ando, et al.
The Journal of Nutritional Biochemistry|December 10, 2014
Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic miceYukiko Kanda, Mitsuru Hashiramoto, Masashi Shimoda, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonistYukiko Kanda, Masashi Shimoda, Sumiko Hamamoto, et al.
Endocrine Journal|August 27, 2009
Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygoteYukiko Kanda, Masashi Shimoda, Kazuhito Tawaramoto, et al.
Diabetology & Metabolic Syndrome|September 22, 2015
Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)Kazuhito Tawaramoto, Hideaki Kaneto, Mitsuru Hashiramoto, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetesTomohiko Kimura, Hideaki Kaneto, Masashi Shimoda, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2009
Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergyFumiko Kawasaki, Shinji Kamei, Fuminori Tatsumi, et al.
Journal of Diabetes Investigation|May 14, 2015
Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infectionShinji Kamei, Hideaki Kaneto, Mitsuru Hashiramoto, et al.
Molecular and Cellular Endocrinology|June 28, 2015
Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expressionHidenori Hirukawa, Hideaki Kaneto, Masashi Shimoda, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2016
Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 DiabetesTomohiko Kimura, Hideaki Kaneto, Yukiko Kanda-Kimura, et al.
Pageof 3